Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegberon vs Pegasys in chronic hepatitis C (phase II)
CTR20140443Phase 2Completed
- Sponsor
- Tebao Biotech
- Start
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2a in hepatitis C virus infection, sponsored by Tebao Biotech. Started Nov 2014; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on CTR20140443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140443.